Tenet Healthcare (THC) is up roughly 3% in Thursday trading (April 9, 2026), with the rally coinciding with the shares moving above their 200-day moving average—often a trigger for systematic and momentum-driven buying. The move is also being reinforced by a still-positive read-through from Tenet’s 2026 financial outlook and commentary pointing to resilient demand trends across its hospitals and ambulatory surgery business.

Tenet’s latest disclosed outlook for 2026 has helped keep sentiment constructive, with investors focused on cash generation, operating discipline, and the company’s ability to compound earnings via its ambulatory surgery footprint. Recent sell-side updates have also kept targets elevated, supporting the idea that the market is willing to pay up for consistent margin execution and capital return.

The next major scheduled catalyst is Tenet’s first-quarter 2026 earnings release, set for Thursday, April 30, 2026, before the market opens, followed by a management call. Into that event, traders will be watching volume trends, any incremental commentary on payer mix and policy headwinds, and whether management reiterates or tightens its 2026 ranges.